Pharmaceuticals 2010, 3(10), 3021-3039; doi:10.3390/ph3103021
Review

Endogenous Matrix-Derived Inhibitors of Angiogenesis

1,* email, 2email and 3email
Received: 10 August 2010; in revised form: 19 September 2010 / Accepted: 25 September 2010 / Published: 28 September 2010
(This article belongs to the Special Issue Angiogenesis Inhibitors)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Endogenous inhibitors of angiogenesis are proteins or fragments of proteins that are formed in the body, which can inhibit the angiogenic process. These molecules can be found both in the circulation and sequestered in the extracellular matrix (ECM) surrounding cells. Many matrix-derived inhibitors of angiogenesis, such as endostatin, tumstatin, canstatin and arresten, are bioactive fragments of larger ECM molecules. These substances become released upon proteolysis of the ECM and the vascular basement membrane (VBM) by enzymes of the tumor microenvironment. Although the role of matrix-derived angiogenesis inhibitors is well studied in animal models of cancer, their role in human cancers is less established. In this review we discuss the current knowledge about these molecules and their potential use as cancer therapeutics and biomarkers.
Keywords: angiogenesis; extracellular matrix; collagen; cancer; therapy; biomarker
PDF Full-text Download PDF Full-Text [404 KB, uploaded 28 September 2010 17:18 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Sund, M.; Nyberg, P.; Eikesdal, H.P. Endogenous Matrix-Derived Inhibitors of Angiogenesis. Pharmaceuticals 2010, 3, 3021-3039.

AMA Style

Sund M, Nyberg P, Eikesdal HP. Endogenous Matrix-Derived Inhibitors of Angiogenesis. Pharmaceuticals. 2010; 3(10):3021-3039.

Chicago/Turabian Style

Sund, Malin; Nyberg, Pia; Eikesdal, Hans Petter. 2010. "Endogenous Matrix-Derived Inhibitors of Angiogenesis." Pharmaceuticals 3, no. 10: 3021-3039.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert